Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(1)
Terminated(1)
Other(1)

Detailed Status

Completed1
Terminated1
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed125%
terminated125%
recruiting125%
unknown125%

Recent Activity

1 active trials
Showing 4 of 4
completednot_applicable

Predictive Model for the Occurrence of Cerebral Vasospasm Complicating Subarachnoid Haemorrhage by Combined Analysis of the Kinetics of a Panel of Biomarkers.

NCT06303349
recruitingnot_applicable

MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy

NCT05333367
terminatednot_applicable

A Clinical and Biological Umbrella Protocol for Smoker or Non-smoker Patients With OPML or HNSCC

NCT03276819
unknown

Study of Copper Isotope in Head and Neck Cancer

NCT02864836

Clinical Trials (4)

Showing 4 of 4 trials
NCT06303349Not Applicable

Predictive Model for the Occurrence of Cerebral Vasospasm Complicating Subarachnoid Haemorrhage by Combined Analysis of the Kinetics of a Panel of Biomarkers.

Completed
NCT05333367Not Applicable

MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy

Recruiting
NCT03276819Not Applicable

A Clinical and Biological Umbrella Protocol for Smoker or Non-smoker Patients With OPML or HNSCC

Terminated
NCT02864836

Study of Copper Isotope in Head and Neck Cancer

Unknown

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4